Advanced Search

 

Study ID Status Title Patient Level Data
114451 Completed Immunogenicity and Safety Study of GSK Biologicals' Seasonal (2010-2011) Influenza Vaccine Fluarix™ in Children Previously Vaccinated With GSK Biologicals' H1N1 Vaccine Pandemrix™ Study Listed on ClinicalStudyDataRequest.com
114452 Completed Immunogenicity and Safety Study of GSK Biologicals' Seasonal (2010-2011) Influenza Vaccine FluarixTM in Adolescents Previously Vaccinated With GSK Biologicals' H1N1 Vaccine PandemrixTM Study Listed on ClinicalStudyDataRequest.com
114454 Terminated Immunogenicity and safety of Fluarix™/ Influsplit SSW® 2010/2011 or Pandemrix™ Study Listed on ClinicalStudyDataRequest.com
114458 Completed A phase 2a study to evaluate the effect of rilapladib (SB-659032) on biomarkers related to the pathogenesis and progression of Alzheimer’s disease Study Listed on ClinicalStudyDataRequest.com
114460 Completed Safety, immunogenicity and efficacy against malaria in the sporozoite challenge model of one dose of Ad35.CS.01 malaria vaccine followed by two doses of malaria 257049 vaccine in healthy malaria-naïve adults Study Listed on ClinicalStudyDataRequest.com
114461 Completed Evaluating the impact of early versus delayed 5 alpha reductase inhibitor treatment on the risk of emergent surgery in men with benign prostatic hyperplasia
114462 Completed Evaluating the treatment patterns in men with benign prostatic hypertrophy (Marketscan database study)
114464 Completed Safety and immunogenicity of monovalent H5N1 vaccine GSK1557484A in children 6 months to < 18 years of age Study Listed on ClinicalStudyDataRequest.com
114471 Completed PGx320 Tykerb TEACH EGF105485 liver safety pharmacogenetics
114482 Completed Demonstrating the clinical and economic benefit of 5 Alpha Reductase Inhibitor adherence in Benign Prostatic Hyperplasia
114495 Completed An observer-blind safety and immunogenicity study of GSK Biologicals’ A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340272A in children 3 to less than 10 years old Study Listed on ClinicalStudyDataRequest.com
114496 Completed A randomised, double-blind, multi-centre study to evaluate the efficacy and safety of inhaled fluticasone furoate in the treatment of persistent asthma in adults and adolescents currently receiving mid to high strength inhaled corticosteroids. Study Listed on ClinicalStudyDataRequest.com
114522 Completed A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic reaction/angioedema-Updated Analysis
114522_1 Completed A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic reaction/angioedema-Updated Analysis
114535 Completed Blinded retrospective laboratory evaluations to assess the serologic response to Porcine circovirus type 1 (PCV-1) in the serum of infants aged 2 and 6 months and toddlers aged 4-6 years following administration of GlaxoSmithKline (GSK) Biologicals’ IPV-containing vaccines
114541 Completed Efficacy study of GSK Biologicals’ quadrivalent influenza vaccine, GSK2282512A, (FLU Q-QIV) when administered in children Study Listed on ClinicalStudyDataRequest.com
114544 Completed A single-blind, randomized, comparative pilot study evaluating the tolerability of two topical combination therapies in the treatment of acne vulgaris Study Listed on ClinicalStudyDataRequest.com
114546 Completed Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Duac® Topical Gel (clindamycin 1% and benzoyl peroxide 5%) to ACANYA™ Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) Topical Acne Medications Study Listed on ClinicalStudyDataRequest.com
114547 Completed A single-blind, randomized, comparative split-face study evaluating the tolerability of clindamycin and benzoyl peroxide gel to benzoyl peroxide/adapalene gel in the treatment of acne vulgaris. Study Listed on ClinicalStudyDataRequest.com
114550 Completed U0289-401: An Evaluator Blinded, 8 Week, Split-Face Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and PROACTIV in Subjects with Acne Study Listed on ClinicalStudyDataRequest.com
114551 Completed U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects with Acne Study Listed on ClinicalStudyDataRequest.com
114552 Completed An open label, randomised, repeat dose study to assess the pharmacokinetic performance of five ezogabine/retigabine modified release (MR) formulations at steady state compared to the immediate release (IR) formulation. Study Listed on ClinicalStudyDataRequest.com
114553 Completed U0289-404: An Evaluator Blinded, 8 Week, Split Face Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITYII and MURAD in Subjects with Acne Study Listed on ClinicalStudyDataRequest.com
114565 Completed A Single-Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects with Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com
114566 Completed A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of Tazorac Cream when used in Combination with Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.